Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4773549 | 0.88 | ALOX15 (0.35) | ALOX15ALDH1A1CYP3A4TDP1 | |
| Cinnamaldehyde SCHEMBL15618525 | 0.85 | ALDH1A1 (0.38) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL4078385 | 0.83 | ALOX15 (0.40) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL1825823 | 0.80 | ALOX15 (0.40) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL16268485 | 0.79 | ALOX15 (0.37) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL2707207 | 0.78 | ALOX15 (0.41) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL13751513 | 0.78 | ALOX15 (0.39) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL4773561 | 0.75 | ALOX15 (0.37) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL1305568 | 0.74 | ALOX15 (0.44) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL4447005 | 0.74 | ALOX15 (0.42) | ALOX15ALDH1A1CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2655307-B1 | COMPOUNDS CAPABLE OF RELEASING FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2018-08-01 | — | — | EP | claimed |
| US-9845449-B2 | Stabilized perfume oils | HENKEL AG & CO. KGAA (DE) | 2017-12-19 | — | — | US | claimed |
| US-9193935-B2 | Compounds capable of releasing fragrant compounds | GIVAUDAN S.A. (CH) | 2015-11-24 | — | — | US | claimed |
| US-8680040-B2 | 1-aza-3,7-dioxabicyclo[3,3,0]octane compounds and monocyclic oxazolidines as pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2014-03-25 | — | — | US | claimed |
| US-20130316938-A1 | Compounds Capable Of Releasing Fragrant Compounds | GIVAUDAN S.A. (CH) | 2013-11-28 | — | — | US | claimed |
| EP-2655307-A1 | COMPOUNDS CAPABLE OF RELEASING FRAGRANT COMPOUNDS | Givaudan SA (CH) | 2013-10-30 | — | — | EP | claimed |
| CN-103319521-A | Cyclic siloxane compositions for the release of active ingredients | GEN ELECTRIC | 2013-09-25 | — | — | CN | claimed |
| EP-2032516-B1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2012-09-26 | — | — | EP | claimed |
| WO-2006102777-A1 | SKIN LIGHTENING METHODS, COMPOSITIONS AND PRODUCTS | GIVAUDAN SA (CH) | 2006-10-05 | — | — | WO | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2006085048-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | FLEXITRAL, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| WO-2005108541-A1 | WASHING COMPOSITIONS | GIVAUDAN SA (CH) | 2005-11-17 | — | — | WO | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| EP-0878497-A2 | Fragrance precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-11-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | ALOX15 868/4885ALDH1A1 44/4885CYP3A4 1847/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | ALOX15 797/4885ALDH1A1 57/4885CYP3A4 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.